Regeneron’s antibody cocktail is a combination of casirivimab and imdevimab, two antibodies that fight against COVID-19. The FDA granted it emergency use authorization Nov. 21.
The West Virginia National Guard said the error does not pose a risk to the 42 individuals. It also said those 42 people “will be offered the vaccine as soon as possible with a priority status,” according to the Washington Post.
More articles on pharmacy:
6 recent drug, device recalls
340B discounts apply to contract pharmacies, HHS clarifies
Pfizer vs. Moderna COVID-19 vaccine: What’s the same & what’s different
6 recent drug, device recalls
